Vanderbilt-Ingram Cancer Center

Patricia Lee, a breast cancer survivor and research advocate with Vanderbilt-Ingram Cancer Center, has just completed an evaluation of research proposals submitted to the Breast Cancer Research Program

by Melissa Marino Compounds known as “HDAC inhibitors” exhibit cancer-killing activities in cultured cells. While they are currently being tested as anti-cancer agents in clinical trials, just how they execute their effects is unclear. In a pair of recent papers, Vanderbilt-Ingram Cancer Center investigators provide a potential mechanism by which HDAC inhibitors specifically damage cancer [...]

Today’s Tennessean features a story on lung cancer (still the leading cancer killer), the need for more research funding and our efforts to develop a non-invasive screening test for it. Here is the link to this important story. The Tennessean

by Dagny Stuart African-Americans are far more likely to be diagnosed with and to die from colorectal cancer than whites or other minority groups. Despite this increased risk, a new study led by Vanderbilt University Medical Center researchers found that African-Americans are far less likely to undergo colonoscopy screening than whites, even when both groups [...]